Direct marketing of pharmaceuticals to consumers.

Revised FDA regulations governing pharmaceutical companies' broadcast advertisements directed to consumers produced substantial increases in direct-to-consumer advertising (DTCA) expenditures. Proponents of DTCA claim it supports patient autonomy in the patient-physician relationship and has motivated some consumers to seek a physician's care for conditions they previously had not discussed with a doctor. However, DTCA's blend of promotion and information has produced more prescription drug awareness than knowledge--it has been largely ineffective in educating patients with medical conditions about the medications for those conditions. The evidence for DTCA's increase in pharmaceutical sales is as impressive as is the lack of evidence concerning its impact on the health of the public. Broadcast advertisements are too brief to include extensive technical information; consequently, the impact of FDA regulations to assure a fair balance of risk and benefit in DTCA is still being assessed.

[1]  M. Hollon.  Direct-to-consumer marketing of prescription drugs: creating consumer demand. , 1999, JAMA.

[2]  R. Kravitz.  Direct-to-Consumer Advertising of Prescription Drugs: Implications for the Patient-Physician Relationship , 2000 .

[3]  Patricia R. Seaver.  Prescription Drug Advertising: An Industry Perspective , 1992 .

[4]  R. Kravitz,et al.  The educational value of consumer-targeted prescription drug print advertising. , 2000, The Journal of family practice.

[5]  L. Morris,et al.  The attitudes of consumers toward direct advertising of prescription drugs. , 1986, Public health reports.

[6]  R. Kravitz,et al.  Health information on the Internet: accessibility, quality, and readability in English and Spanish. , 2001, JAMA.

[7]  L. Green,et al.  An epidemiological approach to targeting drug information. , 1986, Patient Education and Counseling.

[8]  L. Morris,et al.  Counseling patients about prescribed medication: 12-year trends. , 1997, Medical care.

[9]  David Brinberg,et al.  Risk Disclosures in Televised Prescription Drug Advertising to Consumers , 1989 .

[10]  D. Mechanic,et al.  The managed care backlash: perceptions and rhetoric in health care policy and the potential for health care reform. , 2001, The Milbank quarterly.

[11]  L. Basara.  Direct-to-Consumer Advertising: Today's Issues and Tomorrow's Outlook , 1992 .

[12]  J. Cockburn,et al.  Prescribing behaviour in clinical practice: patients' expectations and doctors' perceptions of patients' expectations—a questionnaire study , 1997, BMJ.

[13]  M S Wilkes,et al.  Advertisement-induced prescription drug requests: patients' anticipated reactions to a physician who refuses. , 1999, The Journal of family practice.

[14]  D. Kessler,et al.  The federal regulation of prescription drug advertising and promotion. , 1990, JAMA.

[15]  G. Elwyn,et al.  Shared decision-making in primary care: the neglected second half of the consultation. , 1999, The British journal of general practice : the journal of the Royal College of General Practitioners.

[16]  B Chewning,et al.  Medication decision-making and management: a client-centered model. , 1996, Social science & medicine.

[17]  Jonathan Liebenau,et al.  Taking Your Medicine: Drug Regulation in the United States. , 1982 .

[18]  M. Lipsky,et al.  The opinions and experiences of family physicians regarding direct-to-consumer advertising. , 1997, The Journal of family practice.

[19]  M. P. Gemperli.  MSJAMA: rethinking the role of the learned intermediary: the effect of direct-to-consumer advertising on litigation. , 2000, JAMA.

[20]  J. Zito,et al.  Direct-to-consumer prescription drug advertising. , 1997, Medical care.

[21]  K. A. McKibbon,et al.  Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications , 1996, The Lancet.

[22]  Barbara Gandek,et al.  Patient and Visit Characteristics Related to Physicians' Participatory Decision-Making Style: Results from the Medical Outcomes Study , 1995, Medical care.

[23]  G. Makoul,et al.  Health promotion in primary care: physician-patient communication and decision making about prescription medications. , 1995, Social science & medicine.

[24]  A. F. Holmer,et al.  Direct-to-consumer prescription drug advertising builds bridges between patients and physicians. , 1999, JAMA.

[25]  J. Avorn,et al.  Physician motivations for nonscientific drug prescribing. , 1989, Social science & medicine.

[26]  Pines Wl.  A history and perspective on direct-to-consumer promotion. , 1999 .